Uveitis Following Intravitreal Injections of Faricimab: A Case Report

被引:13
作者
Palmieri, Filomena [1 ]
Younis, Saad [1 ]
Hamoud, Aseel Bedan [1 ]
Fabozzi, Lorenzo [1 ,2 ]
机构
[1] Western Eye Hosp, Imperial Coll Healthcare NHS Trust, 153-173 Marylebone Rd, London NW1 5QH, England
[2] Moorfields Eye Hosp NHS Fdn Trust, Med Retina Dept, London, England
关键词
AntiVEGF; DMO; faricimab; nAMD; uveitis; ACUTE INTRAOCULAR INFLAMMATION; MACULAR DEGENERATION; BEVACIZUMAB; RANIBIZUMAB; STABILITY; AGENTS;
D O I
10.1080/09273948.2023.2293925
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposeFaricimab, a novel pharmaceutical agent targeting both angiopoietin-2 and vascular endothelial growth factor-A pathways, has gained approval for treating neovascular age-related macular degeneration and diabetic macular oedema. While clinical trials have demonstrated its favorable safety profile, this research presents two cases of hypertensive uveitis following intravitreal Faricimab injections.MethodsMedical history, clinical findings and multimodal images were retrospectively collected.ResultsThe patients experienced elevated intraocular pressure, mutton-fat keratic precipitates, anterior and posterior segment inflammation shortly after faricimab administration.ConclusionsThese cases prompt further investigation into the potential risk of uveitis associated with faricimab and underscore the importance of continued monitoring and research to elucidate its real-world safety profile.
引用
收藏
页码:1873 / 1877
页数:5
相关论文
共 27 条
[1]   Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review [J].
Anderson, William J. ;
da Cruz, Natasha Ferreira Santos ;
Lima, Luiz Henrique ;
Emerson, Geoffrey G. ;
Rodrigues, Eduardo Buchele ;
Melo, Gustavo Barreto .
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
[2]   Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives [J].
Baeshen, Mohammed N. ;
Al-Hejin, Ahmed M. ;
Bora, Roop S. ;
Ahmed, Mohamed M. M. ;
Ramadan, Hassan A. I. ;
Saini, Kulvinder S. ;
Baeshen, Nabih A. ;
Redwan, Elrashdy M. .
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 25 (07) :953-962
[3]   BEVACIZUMAB VERSUS RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Meta-analysis of Randomized Controlled Trials [J].
Chen, Guohai ;
Li, Wensheng ;
Tzekov, Radouil ;
Jiang, Fangzheng ;
Mao, Sihong ;
Tong, Yuhua .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (02) :187-193
[4]   Inflammatory Complications of Intravitreal Anti-VEGF Injections [J].
Cox, Jacob T. ;
Eliott, Dean ;
Sobrin, Lucia .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) :1-16
[5]   Ocular inflammation associated with antivascular endothelial growth factor treatment [J].
Fine, Howard F. ;
Despotidis, Greg D. ;
Prenner, Jonathan L. .
CURRENT OPINION IN OPHTHALMOLOGY, 2015, 26 (03) :184-187
[6]   FREQUENCY AND CHARACTERISTICS OF INTRAOCULAR INFLAMMATION AFTER AFLIBERCEPT INJECTION [J].
Fine, Howard F. ;
Roth, Daniel B. ;
Shah, Sumit P. ;
Haque, Tahia ;
Wheatley, Matthew .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (04) :681-686
[7]   Pegaptanib for neovascular age-related macular degeneration [J].
Gragoudas, ES ;
Adamis, AP ;
Cunningham, ET ;
Feinsod, M ;
Guyer, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2805-2816
[8]   Aflibercept-Related Sterile Intraocular Inflammation Outcomes [J].
Greenberg, Jonathan P. ;
Belin, Peter ;
Butler, John ;
Feiler, Daniel ;
Mueller, Christian ;
Tye, Andrew ;
Friedlander, Steven M. ;
Emerson, Geoffrey G. ;
Ferrone, Philip J. .
OPHTHALMOLOGY RETINA, 2019, 3 (09) :753-759
[9]   Aflibercept-Related Sterile Inflammation [J].
Hahn, Paul ;
Kim, Judy E. ;
Stinnett, Sandra ;
Chung, Mina M. ;
Dugel, Pravin U. ;
Flynn, Harry W., Jr. ;
Huang, Suber S. ;
Sadda, SriniVas R. ;
Mahmoud, Tamer H. .
OPHTHALMOLOGY, 2013, 120 (05) :1100-1101
[10]  
Heier, 2007, ARCH OPHTHALMOL-CHIC, V125, P138